Author Question: When selecting an identifier, one should: A) use intelligent keys. B) use large composite keys ... (Read 62 times)

folubunmi

  • Hero Member
  • *****
  • Posts: 524
When selecting an identifier, one should:
 
  A) use intelligent keys.
  B) use large composite keys instead of single-attribute surrogate keys.
  C) choose a candidate key that will not change its value over the life of each instance of the entity type.
  D) choose a candidate key such that for each instance of the entity, the attribute is guaranteed to have valid values or is null.
  E) choose a candidate key that allows for duplicate values.

Question 2

On a data-flow diagram, you may:
 
  A) repeat data stores and processes.
  B) repeat sources/sinks and processes.
  C) only repeat processes.
  D) repeat relationships.
  E) repeat both data stores and sources/sinks.



mtmmmmmk

  • Sr. Member
  • ****
  • Posts: 335
Answer to Question 1

C
Explanation: C) An identifier uniquely identifies an entity instance. Because of this role, it cannot be null.
CL

Answer to Question 2

E
Explanation: E) While you may repeat data stores, sinks and sources, there is no reason to have two processes with the same name.
CL



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

In ancient Rome, many of the richer people in the population had lead-induced gout. The reason for this is unclear. Lead poisoning has also been linked to madness.

Did you know?

The shortest mature adult human of whom there is independent evidence was Gul Mohammed in India. In 1990, he was measured in New Delhi and stood 22.5 inches tall.

Did you know?

Chronic necrotizing aspergillosis has a slowly progressive process that, unlike invasive aspergillosis, does not spread to other organ systems or the blood vessels. It most often affects middle-aged and elderly individuals, spreading to surrounding tissue in the lungs. The disease often does not respond to conventionally successful treatments, and requires individualized therapies in order to keep it from becoming life-threatening.

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

Did you know?

Patients who cannot swallow may receive nutrition via a parenteral route—usually, a catheter is inserted through the chest into a large vein going into the heart.

For a complete list of videos, visit our video library